top of page

Blair Medical Group

Analytical Hub

The Pathway

Patient Outcomes

BCP Science

EXHIBIT 2.04B • CONFOCAL FLUORESCENCE • MAGENTA AXONS & NEON GREEN MICROGLIA
Cellular Regulatory Report

Visualizing the

Neural Rescue

Microglia for brain health  

Analyze the Switch
Clinical Workflow

Aggressive Amoeboid

The microglial cell body swells and retracts its processes, adopting a jagged shape that initiates neurotoxic chemical release.

High density Cytokines & Reactive Oxygen Species.

Synaptic pruning & Chronic Myelin Degradation.

Neural Phenotype Laboratory

This analytical section simulates the microglial polarization process. By toggling the receptor agonist, we observe the cellular and chemical shift from the M1 (Arsonist) to the M2 (Architect) state.

System Alert: Pro-Inflammatory Polarization Active

M1: Inflammation

Pathological

Pathological

M2: Restoration

Therapeutic

The Agonism Workflow

Strategic regulation of neuro-immune polarization.

01

Insult

Systemic stress triggers M1 polarization, beginning the inflammatory cycle.

02

Agonism

BCP introduces high-affinity ligands to the cortical micro-environment.

03

Engagement

Binding to CB2 receptors triggers an intracellular G-protein conformational shift.

04

Restoration

The phenotype resets to M2, clearing toxic plaques and restoring connectivity.

Clinical Outcomes

Comparing disease progression vs. therapeutic rescue.

M1: Decline

Cognitive Erosion

Memory fragmentation and disorientation via chronic synaptic loss.

Motor Instability

Pathological tremors (4-6 Hz) and decreased coordination.

Neuro-Psychiatric Stress

Heightened anxiety and depressive states from internal inflammation.

M2: Rescue

Synaptic Recovery

Rescued recall and clarity as microglial phagocytosis clears debris.

Structural Stability

Restored myelin sheaths resulting in fluid motor function.

Cerebral Equilibrium

Stabilized mood and increased neurological resilience.

BMG Apothecary Data

Beta-Caryophyllene:

A Selective Regulatory Key

Clinical transition is catalyzed by

Beta-Caryophyllene (BCP)

. As a selective CB2 agonist, it uniquely bypasses the psychoactive CB1 receptors entirely.

Our therapeutic framework utilizes BCP to initiate "cellular cleanup" without intoxication, leveraging 99.8% receptor specificity for targeted neuroprotection.

Pepper Essence

Clove Extracts

Herb Isolates

Binding Affinity Matrix

BCP SELECTIVITY FACTOR VS CB1 > 1000x

OPTIMIZED DOSAGE CALIBRATION • BMG-772

DATA PLATE 4.2B

Structural Receptor Engagement Model

"Precision regulation of the neuro-immune system is the frontier of self-repair."

Blair Medical Group • Neuro-Apothecary Division • © 2026

bottom of page